" class="no-js "lang="en-US"> Caris Life Sciences Archives - Medtech Alert
Saturday, September 30, 2023

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

New Research from the Caris Precision Oncology Alliance Finds Prognostic and Predictive Drug-Induced Gene Signatures for Colorectal Cancer Patients

Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering […]

Caris Life Sciences and HotSpot Therapeutics Announce Collaboration to Advance Precision Medicine Development for Difficult-to-Drug Therapeutic Targets

Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]

Caris Life Sciences Announces Appointment of Rob Clark as Chief Communications Officer

Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced today […]

Caris Life Sciences Announces Appointment of Lloyd B. Minor to Board of Directors

Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]

Caris Precision Oncology Alliance Announces the Addition of Columbia University Irving Medical Center to Its Collaborative Network of Precision Medicine Experts

Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]

Caris’ Precision Oncology Alliance Welcomes The Georgia Cancer Center at Augusta University

Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative […]

Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts

Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more